Entero Healthcare Solutions Limited (NSE:ENTERO)
India · Delayed Price · Currency is INR 1,179.30
-8.40 (-0.71%)
Jul 18, 2025, 3:29 PM IST
NSE:ENTERO Revenue
In the fiscal year ending March 31, 2025, Entero Healthcare Solutions had annual revenue of 50.96B INR with 29.92% growth. Entero Healthcare Solutions had revenue of 13.39B in the quarter ending March 31, 2025, with 29.48% growth.
Revenue
50.96B
Revenue Growth
+29.92%
P/S Ratio
1.01
Revenue / Employee
15.73M
Employees
3,240
Market Cap
51.31B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Glenmark Pharmaceuticals | 134.35B |